在注射SARS-CoV-2的小鼠中,Afucosylated IgG促进了血栓形成,突起表达巨核细胞
Meryem Mabrouk1, Farah Atifi1, Hicham Wahnou2
1Materials, Nanotechnologies and Environment Laboratory, Department of Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10100, Morocco.
International journal of molecular sciences
|July 29, 2025
概括
在COVID-19患者中,IgG抗体 (afucosylated IgGs) 的低基化向尖端蛋白,导致严重的疾病. 准FcγRIIa或相关途径可以预防相关的血栓形成和肺损伤.
科学领域:
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
- 血液学 血液学 血液学
背景情况:
- 福科化IgG是常见的,但在病毒感染期间发生特定IgG的低福科化 (afucosylation).
- 针对SARS-CoV-2尖端蛋白的Afucosylated IgG与严重的COVID-19有关.
- 这种afucosylation在SARS-CoV-2和登革热等感染的发病过程中发挥着作用.
研究的目的:
- 在SARS-CoV-2感染中研究致病性afucosylated抗尖峰IgG的产生.
- 探索病毒感染,免疫反应和静血并发症之间的联系.
- 为了确定严重的COVID-19结果的潜在治疗点.
主要方法:
- 研究了FcγRIIa转基因小鼠中巨核细胞的SARS-CoV-2感染和随后的IgG生成.
- 评估了血小板激活生物标志物和血栓形成,以应对感染病毒的巨核细胞.
- 评估了FcγRIIa,血清素和补充抑制剂在预防不良结果方面的疗效.
主要成果:
- 巨核细胞的SARS-CoV-2感染产生了致病性afucosylated抗尖峰IgG.
- 这些IgG导致肺血管血栓形成,急性肺损伤和小鼠死亡.
- 巨核细胞的病毒感染直接激活了血小板,并促进了血栓的形成.
- 抑制剂治疗成功地预防了血小板激活,血栓形成和出血问题.
结论:
- 由于SARS-CoV-2引起的巨核细胞感染,会产生afucosylated IgG,导致严重的COVID-19病理.
- 亚福基化IgG将病毒感染与血小板激活和血栓性并发症联系起来.
- 针对FcγRIIa,血清素或补充通路提供了潜在的治疗策略.
更多相关视频
09:54Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
3.6K
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
847
相关概念视频
Blood Transfusion and Agglutination
11.2K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.2K
Transcytosis of IgG
2.9K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.9K
